Jun 08,2015

Tandem Diabetes Care Announces t:simulator™ App Now Available for Android Devices

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that the t:simulator™ App is now available for devices using the Android operating system. The t:simulator App mirrors the same steps used on a t:slim Pump for the most commonly used insulin pump tasks.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 08,2015

BD and Medtronic Collaborate to Introduce a New Infusion Set with BD FlowSmart(TM) Technology Designed to Improve Insulin Pump Therapy

BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), and Medtronic (NYSE: MDT) today announced a collaboration to introduce a new...

COLLABORATION PARTNERSHIP

#product & service

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 08,2015

LabStyle Innovations Late Breaking Poster Presented at American Diabetes Association 75th Scientific Session

Dr. Paul Rosman, a member of the LabStyle Innovations Scientific Advisory Board, delivered the presentation at the ADA's Scientific Session that brings together over 14,000 participants from 124 countries. The poster revealed the results of a 368 patient Diabetes Type 1 and Type 2 study that was performed in the United States. Results of the study, which was carried out in Ohio, showed that the Dario™ Blood Glucose Monitoring System meets the acceptance criteria of new more stringent ISO 15197:2013. 97.8% of the Dario glucose results fall within + 0.83 mmol/L (15 mg/dL) at glucose concentrations < 5.5 mmol/L (< 100 mg/dL) and 96.49% of the Dario glucose results fall within + 15% at glucose concentrations >5.5 mmol/L (>100 mg/dL).

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
Jun 15,2015

BD Opens Advance Diabetes Care Headquarters in Andover, Mass.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, officially opened its Advanced Diabetes Care facility in Andover, Mass., which will house research and development (R&D) and manufacturing of novel solutions for Type 1 and Type 2 diabetes.

View Analyst & Ambassador Comments
Go to original news
Jun 25,2015

1Drop Wins the W.A. De Vigier Award

1Drop, saving lives through better and faster portable medical diagnostics, is among the 5 winners of the W.A. De Vigier Award 2015. The De Vigier Award is one of the most prestigious entrepreneurship prizes in Switzerland. It is the oldest prize with the highest endowment. A prize of CHF 100‘000 is given to five start-ups each year.

View Analyst & Ambassador Comments
Go to original news
Jun 25,2015

LabStyle Innovations' Dario Diabetes Management Solution Launches in Canada

On the heels of receiving regulatory approval in Canada for the Dario™ Diabetes Management Solution, LabStyle Innovations Corp. (DRIO), today announced the Dario is now available for sale in Canada. The compact all-in-one system that helps people with diabetes monitor blood sugar levels and proactively manage their disease using their smartphone or tablet, is distributed by Auto Control Medical. Now available through www.mydario.ca, Dario's suggested retail price is $39.95 and it will be available at selected pharmacies including London Drugs.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Jun 30,2015

Insulet Announces Organizational Changes

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced a series of organizational changes designed to continue its focus on improving operational performance and to drive faster communication and greater integration between departments.

View Analyst & Ambassador Comments
Go to original news
Jul 08,2015

Roche launches FDA-cleared diabetes app with insulin calculator in US

Last month, Roche quietly launched its Accu-Chek Connect app, a diabetes management app which contains, among other things, an unprecented feature: a prescription insulin bolus calculator called Bolus Advisor. Roche has been selling the app in other countries for a little while, even issuing a brief recall in April in some of those countries. It received FDA clearance for the Android version of the app in mid-March and finally received clearance for the iOS version in early June, using the Android clearance as the predicate device.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 14,2015

Welkin Health gets $2M for disease management coaching tools, Humana pilot

Welkin Health, a San Francisco-based population health management company that provides a combination of mobile, web, and telephone-based coaching programs, has raised $2 million in seed funding and announced its first major pilot, which is with Humana's Innovation Group. Investors in the seed round include Rock Health, Asset Management Ventures, Great Oaks VC, iSeed VC, a direct investment from iKang Healthcare Group, and Mayo Clinic. iKang is the largest preventative healthcare group in mainland China.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jul 15,2015

Eli Lilly's Glucagon app now available for Android

Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon , which is designed to help caregivers and providers treat people with diabetes if they fall into an insulin coma. The app helps the user feel prepared to use Glucagon, which is a prescription drug that must be injected. The Glucagon app allows the user to practice the steps for administering Glucagon, using the touchscreen simulator. It also allows users to record the locations of Glucagon kits so one can be located in an emergency. It also tracks expiration dates of...

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES